TY  - GEN
AU  - Lukasiewicz,E
AU  - Gorfine,M
AU  - Freedman,L S
AU  - Pawlotsky,J-M
AU  - Schalm,S W
AU  - Ferrari,C
AU  - Zeuzem,S
AU  - Neumann,A U
TI  - Prediction of nonSVR to therapy with pegylated interferon-alpha2a and ribavirin in chronic hepatitis C genotype 1 patients after 4, 8 and 12 weeks of treatment
SN  - 1365-2893
PY  - 2010///0722
KW  - Adult
KW  - Age Factors
KW  - Antiviral Agents
KW  - therapeutic use
KW  - Body Mass Index
KW  - Female
KW  - Genotype
KW  - Hepacivirus
KW  - classification
KW  - Hepatitis C, Chronic
KW  - drug therapy
KW  - Humans
KW  - Interferon alpha-2
KW  - Interferon-alpha
KW  - Male
KW  - Middle Aged
KW  - Models, Statistical
KW  - Polyethylene Glycols
KW  - Prognosis
KW  - RNA, Viral
KW  - blood
KW  - Recombinant Proteins
KW  - Ribavirin
KW  - Sex Factors
KW  - Time Factors
KW  - Treatment Failure
KW  - Viral Load
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1365-2893.2009.01183.x
ER  -